These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 8378280)
1. [Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania]. Ragnaud JM; Morlat P; Dupon M; Lacoste D; Pellegrin JL; Chene G Presse Med; 1993 May; 22(19):903-8. PubMed ID: 8378280 [TBL] [Abstract][Full Text] [Related]
2. Cerebral toxoplasmosis and AIDS. Clinical, neuroradiological and immunological findings in 15 patients. Orefice G; Carrieri PB; Chirianni A; Rubino S; Liuzzi G; Napolitano G; Rocco A Acta Neurol (Napoli); 1992; 14(4-6):493-502. PubMed ID: 1293991 [TBL] [Abstract][Full Text] [Related]
3. [Recurrence of cerebral toxoplasmosis in 15 AIDS patients]. Walckenaer G; Leport C; Longuet P; Perronne C; Lacassin F; Vildé JL Ann Med Interne (Paris); 1994; 145(3):181-4. PubMed ID: 8092633 [TBL] [Abstract][Full Text] [Related]
4. [Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients]. Ferrer S; Fuentes I; Domingo P; Muñoz C; Iranzo A; Barrio JL; Fuster M; Ris J; Sambeat MA; Cadafalch J; Nolla J An Med Interna; 1996 Jan; 13(1):4-8. PubMed ID: 8679824 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. Guelar A; Miró JM; Mallolas J; Zamora L; Cardenal C; Gatell JM; Soriano E Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):137-40. PubMed ID: 8011719 [TBL] [Abstract][Full Text] [Related]
6. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting. Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350 [TBL] [Abstract][Full Text] [Related]
7. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections. Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia. Tsai HC; Lee SS; Lin HH; Lin WR; Chen YS; Huang CK; Liu YC; Chen ER J Formos Med Assoc; 2002 Sep; 101(9):646-9. PubMed ID: 12645193 [TBL] [Abstract][Full Text] [Related]
9. Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. Laing RB; Flegg PJ; Brettle RP; Leen CL; Burns SM Int J STD AIDS; 1996 Jul; 7(4):258-64. PubMed ID: 8876356 [TBL] [Abstract][Full Text] [Related]
10. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493 [TBL] [Abstract][Full Text] [Related]
11. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627 [TBL] [Abstract][Full Text] [Related]
12. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183 [TBL] [Abstract][Full Text] [Related]
13. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. Katlama C Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):189-91. PubMed ID: 2060527 [TBL] [Abstract][Full Text] [Related]
15. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis. Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561 [TBL] [Abstract][Full Text] [Related]
17. Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome. Winstanley P Postgrad Med J; 1995 Jul; 71(837):404-8. PubMed ID: 7567731 [TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients. Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949 [TBL] [Abstract][Full Text] [Related]
19. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994]. Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164 [TBL] [Abstract][Full Text] [Related]
20. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient]. Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]